IRIS
SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.015
AS - Asia 1.380
EU - Europa 866
SA - Sud America 381
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 40
OC - Oceania 7
Totale 5.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.848
SG - Singapore 390
IT - Italia 388
BR - Brasile 297
BD - Bangladesh 220
CN - Cina 214
HK - Hong Kong 201
TR - Turchia 139
IE - Irlanda 132
CA - Canada 94
VN - Vietnam 92
FR - Francia 69
GB - Regno Unito 62
DE - Germania 57
SE - Svezia 41
AR - Argentina 28
NL - Olanda 28
MX - Messico 26
IN - India 23
EC - Ecuador 20
PL - Polonia 20
CR - Costa Rica 17
CO - Colombia 16
ZA - Sudafrica 16
AT - Austria 14
ID - Indonesia 13
FI - Finlandia 12
IQ - Iraq 12
IL - Israele 11
PY - Paraguay 8
SA - Arabia Saudita 8
GT - Guatemala 7
JP - Giappone 7
PK - Pakistan 7
AU - Australia 6
ES - Italia 6
MA - Marocco 6
RU - Federazione Russa 6
UZ - Uzbekistan 6
EG - Egitto 5
GR - Grecia 5
JM - Giamaica 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
MY - Malesia 4
TN - Tunisia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
EE - Estonia 2
GP - Guadalupe 2
HN - Honduras 2
LV - Lettonia 2
PA - Panama 2
PR - Porto Rico 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.690
Salva come PNG Salva come JPEG
Città #
Dallas 928
Ashburn 237
San Jose 211
Hong Kong 197
Singapore 167
Dublin 132
Santa Clara 104
The Dalles 96
Los Angeles 73
New York 70
Beijing 69
Istanbul 67
Boardman 61
Chicago 60
Council Bluffs 54
Phoenix 46
Ankara 43
Rome 43
Ho Chi Minh City 32
Milan 27
San Francisco 27
São Paulo 25
Montreal 24
Naples 24
Hanoi 21
Frankfurt am Main 18
Hillsboro 17
Warsaw 17
Palermo 16
Buffalo 15
Brooklyn 14
Amsterdam 13
Boston 13
Denver 13
Mexico City 13
Munich 13
Orem 13
Brasília 12
Rio de Janeiro 12
San José 12
Atlanta 11
Seattle 11
Bologna 10
Chennai 10
Helsinki 10
Princeton 10
Rimini 10
Toronto 10
Vienna 9
Abbeville 8
Catania 8
London 8
Paris 8
York 8
Haiphong 7
Johannesburg 7
Mishmar HaShiv`a 7
Assago 6
Bari 6
Bursa 6
Curitiba 6
Florence 6
Fortaleza 6
Guatemala City 6
Guayaquil 6
Miami 6
Nuremberg 6
Philadelphia 6
Queens 6
Reston 6
Stockholm 6
Stony Brook 6
Tashkent 6
Turin 6
Verona 6
Athens 5
Düsseldorf 5
Guangzhou 5
Limburg an der Lahn 5
Manassas 5
Modena 5
Nijmegen 5
Quito 5
Recife 5
San Diego 5
Vancouver 5
Belo Horizonte 4
Bogotá 4
Cairo 4
Calgary 4
Charlotte 4
Divinópolis 4
Goiânia 4
Manchester 4
Newark 4
Padua 4
Pasadena 4
Passaic 4
Riccione 4
Seoul 4
Totale 3.420
Salva come PNG Salva come JPEG
Nome #
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 590
Anhedonia: Current and future treatments 335
Depression: Understanding and Managing Antidepressant Side Effects 105
Understanding and treating postpartum depression: a narrative review 105
A comprehensive overview of post-stroke depression treatment options 104
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 102
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation 89
Resistance to Change from a Psychological Perspective 89
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence 88
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.] 87
Expanding treatment domains across psychiatric disorders 85
Treatment-Resistant Depression: When and How Should It Be Referred? 84
A Clinically Oriented Review of New Antipsychotics for Schizophrenia 83
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance 82
Anhedonia and Depressive Disorders 79
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 79
Suicide ideation and male-female differences in major depressive disorder 79
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 77
Mental fatigue in individuals with psychiatric disorders: a scoping review 75
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting 73
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 73
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality 72
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 72
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors 71
A Critical View on New and Future Antidepressants 71
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets? 70
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 69
Afternoon Keynote Genetic and Clinical Predictors of Antidepressant Response 67
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology 66
Age as a moderating factor of treatment resistance in depression 65
Genomics yields biological and phenotypic insights into bipolar disorder 65
Anhedonia is associated with a specific depression profile and poor antidepressant response 64
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two {UK} cohorts 64
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 63
Understanding mood disorder treatments 63
Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders 62
Antidepressant treatment in complex clinical pictures 62
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics 61
Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank 58
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors 58
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 55
The pharmacological management of treatment-resistant depression: what does the future hold? 53
Focus on neurodevelopmental conditions and antipsychotics prescription patterns 52
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 51
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path 51
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments 50
Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine 50
Mirtazapine blood levels and antidepressant response 49
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient 44
The clinical perspective on late-onset depression in European real-world treatment settings 43
Mood disorders and somatic comorbidities 40
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder 38
Psychological impact of neovagina creation and uterus transplantation in the patients affected from Mayer–Rokitanski–Kuster–Hauser syndrome: A narrative review 38
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis 37
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders 36
Modulating factors in mood disorders treatment 36
Clinical predictors of treatment resistant depression 36
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 33
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis 33
Shared genetics and causal relationship between sociability and the brain's default mode network 31
Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review 31
The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature 28
Passive suicide ideation in major depressive disorder: prognostic role and effect of antidepressant treatment 28
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 27
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study 27
Further evidence of depressive symptomatology profile predicting treatment outcome 26
Moving toward precision and personalized treatment strategies in psychiatry 25
Gait and Hearing Performance in Cognitively Unimpaired Adults: A Sex-Stratifyed Analysis 24
The impact of depression on functioning: Relation to medication response and other predictors 23
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood Disorders 23
Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice 23
Defining and assessing international classification of disease suicidality phenotypes for genetic studies 23
Schizophrenia Genetics Modulates Clinical Depressive Features 23
Oropharyngeal microbiota in patients with psychotic disorders: A scoping review on compositional and functional alterations 22
Insulin resistance and poorer treatment outcomes in depression: Evidence from UK Biobank primary care data 22
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group 22
Mild motor signs and depression: more than just medication side effects? 22
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients 21
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis 21
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data 21
Fine-mapping genomic loci refines bipolar disorder risk genes 21
Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review 21
Neuropsychiatric Symptoms and Alzheimer’s Disease Severity. A Focus on Sex-Differences 20
Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson’s disease and Lewy bodies dementia 19
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectiveness 18
Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions 18
Symptom networks in major depressive disorder and treatment response: special focus on TRD 17
Innovations and challenges in antipsychotic treatments and external modulating factors 17
The genetics of treatment-resistant depression: controversies and perspectives 16
Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation 16
Unsolved Issues in Anhedonia: A Call for Targeted Inquiry 16
Differences in emotion recognition between nonimmersive versus immersive virtual reality: Preliminary findings in schizophrenia and bipolar disorder 15
Immersive Technologies for Cognitive Rehabilitation in Dementia and Mild Cognitive Impairment: Systematic Review 15
Treatment options for depression in Parkinson's disease: a mini-review 15
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study 14
Evidence based interventions for bipolar disorder across phases and age groups: living umbrella review, evaluation, analysis, and communication hub (U-REACH) project 14
Frontal lobes dysfunction across clinical clusters of acute schizophrenia 14
Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts 14
Neuropsychiatric characteristics of capgras syndrome in Alzheimer's disease in the CATIE-AD 13
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways 13
Totale 5.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024229 0 0 0 0 0 0 0 17 30 37 80 65
2024/2025917 45 26 39 31 86 55 33 41 178 180 144 59
2025/20263.377 138 418 738 252 84 172 201 331 292 308 237 206
2026/20271.338 79 213 575 471 0 0 0 0 0 0 0 0
Totale 5.861